Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FNMWV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,737
Award facts
- Contract value 100% obligated
- $7,737.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL syringes. The award was made on September 8, 2025, with an ultimate completion date of September 29, 2025, under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. Xolair is a biologic medication used to treat moderate-to-severe allergic asthma and other allergic conditions, representing the type of specialized pharmaceutical products the company regularly supplies to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, which carries a total contract value of $499,999,999 and extends through November 2026. This IDC vehicle enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support Department of Defense healthcare facilities worldwide. The company's contract portfolio demonstrates consistent success in competing for federal pharmaceutical supply contracts and reflects its established position as a critical supplier within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FNMWV?
SPE2DB25FNMWV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FNMWV worth?
The government has obligated $7,737 on SPE2DB25FNMWV.
Is contract SPE2DB25FNMWV an order under another contract?
Yes. SPE2DB25FNMWV is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWV competed?
The extent of competition for SPE2DB25FNMWV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award